GSK plc Statistics

Total Valuation

GSK plc has a market cap or net worth of 73.73 billion. The enterprise value is 89.54 billion.

Market Cap	73.73B
Enterprise Value	89.54B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Feb 20, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.75%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.94B

Valuation Ratios

The trailing PE ratio is 22.87.

PE Ratio	22.87
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.67, with an EV/FCF ratio of 13.87.

EV / Earnings	27.78
EV / Sales	2.26
EV / EBITDA	7.67
EV / EBIT	10.79
EV / FCF	13.87

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.30.

Current Ratio	0.78
Quick Ratio	0.52
Debt / Equity	1.30
Debt / EBITDA	1.84
Debt / FCF	3.30
Interest Coverage	9.82

Financial Efficiency

Return on equity (ROE) is 22.80% and return on invested capital (ROIC) is 13.49%.

Return on Equity (ROE)	22.80%
Return on Assets (ROA)	6.93%
Return on Invested Capital (ROIC)	13.49%
Return on Capital Employed (ROCE)	17.39%
Revenue Per Employee	559,454
Profits Per Employee	45,914
Employee Count	70,212
Asset Turnover	0.53
Inventory Turnover	1.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.83% in the last 52 weeks. The beta is 0.34, so GSK plc's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-13.83%
50-Day Moving Average	17.20
200-Day Moving Average	19.26
Relative Strength Index (RSI)	54.55
Average Volume (20 Days)	2,325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GSK plc had revenue of 39.28 billion and earned 3.22 billion in profits. Earnings per share was 0.78.

Revenue	39.28B
Gross Profit	28.21B
Operating Income	8.22B
Pretax Income	4.35B
Net Income	3.22B
EBITDA	11.57B
EBIT	8.22B
Earnings Per Share (EPS)	0.78

Full Income Statement

Balance Sheet

The company has 4.87 billion in cash and 21.27 billion in debt, giving a net cash position of -16.39 billion.

Cash & Cash Equivalents	4.87B
Total Debt	21.27B
Net Cash	-16.39B
Net Cash Per Share	n/a
Equity (Book Value)	16.38B
Book Value Per Share	4.19
Working Capital	-5.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.21 billion and capital expenditures -1.75 billion, giving a free cash flow of 6.45 billion.

Operating Cash Flow	8.21B
Capital Expenditures	-1.75B
Free Cash Flow	6.45B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.81%, with operating and profit margins of 20.94% and 8.21%.

Gross Margin	71.81%
Operating Margin	20.94%
Pretax Margin	11.08%
Profit Margin	8.21%
EBITDA Margin	29.45%
EBIT Margin	20.94%
FCF Margin	16.43%

Dividends & Yields

This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 4.25%.

Dividend Per Share	0.77
Dividend Yield	4.25%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	94.91%
Buyback Yield	-0.75%
Shareholder Yield	3.50%
Earnings Yield	4.37%
FCF Yield	8.75%

Dividend Details

Stock Splits

The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.

Last Split Date	Jul 19, 2022
Split Type	Reverse
Split Ratio	0.8

Scores

GSK plc has an Altman Z-Score of 1.81. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.81
Piotroski F-Score	n/a